Better Use Case
How immunotherapy could be used to treat infectious diseases
Maryam Mahdi | | Quick Read
Though TCR therapies are typically associated with treating cancer, researchers from Duke-NUS Medical School believe they could offer therapeutic value in various infectious diseases, including hepatitis B (HBV), HIV, and COVID-19 (1).
“There is more definitive data showing that virus-specific CD8 T cells (white blood cells that kill damaged cells) are important for the control of viral infections than solid cancers. But most cell therapies target tumors,” says Antonio Bertoletti, a professor at Duke-NUS Medical School. “This pushed us to investigate whether similar results could be achieved in HBV and COVID-19.”
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.